LATIN AMERICA
Sales come mainly through the public sector -bidding and institutional sales , mostly- , sales from private healthcare , including sales figures from innovative products ( such as Copaxone ® and Azilect ®), and as well as from “ over the counter ” products .
Key People
Also , TP Mexico has diversified its portfolio in three important areas of the healthcare industry : medical research , product development and drug manufacturing .
Teva ’ s operation in Mexico includes four production centers supplying the domestic market , mostly ; as well as other markets in Latin America .
Teva worldwide
Enrique Villarreal CEO
Villarreal majored in industrial engineering at ITESM , and afterwards took global management postgraduate studies at Thunderbird School of Global Management , in Arizona , U . S .
His corporate career started in 1994 , in Grupo Gamesa , being in charge of database design and creation from raw material , as part of the general inventory . Two years later , his skills took him up the ladder as a Financial Officer , where he focused on the annual business plan , with basis from his nationwide market analysis .
He joined the pharmaceutical industry in June 1998 as data systems manager for the Quimica y Farmacia company , managing budgets of more than $ 2 million , creating synergy with other companies such as Perrigo Mexico , which later on hired him as supply chain manager on March 2001 and as COO in January 2003 .
After a decade ’ s worth of experience in the pharmaceutical industry , Teva Pharmaceuticals selected Villarreal to manage the Mexico branch , starting October 2011 , taking care of a leading drug manufacturing company in Mexico and in charge of global business transactions .
www . tevamexico . com 85